{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:34:05Z","timestamp":1794350045715,"version":"4.9.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T00:00:00Z","timestamp":1396396800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2466-14-56","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T23:32:37Z","timestamp":1396481557000},"source":"Crossref","is-referenced-by-count":25,"title":["Real-life use of fluticasone propionate\/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study"],"prefix":"10.1186","volume":"14","author":[{"given":"Nicolas","family":"Roche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Pribil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Van Ganse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Serrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Housset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9borah","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Texier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Sch\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Boucot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,2]]},"reference":[{"key":"496_CR1","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","volume":"349","author":"CJ Murray","year":"1997","unstructured":"Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990\u20132020: Global Burden of Disease Study. Lancet. 1997, 349: 1498-1504. 10.1016\/S0140-6736(96)07492-2.","journal-title":"Lancet"},{"key":"496_CR2","volume-title":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease","author":"GOLD","year":"2014","unstructured":"GOLD: Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2014, Available from http:\/\/www.goldcopd.org\/guidelines-global-strategy-for-diagnosis-management.html . (Accessed April 2014)"},{"key":"496_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1465-9921-10-59","volume":"10","author":"CR Jenkins","year":"2009","unstructured":"Jenkins CR, Jones PW, Calverley PM, Celli B, Anderson JA, Ferguson GT, Yates JC, Willits LR, Vestbo J: Efficacy of salmeterol\/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res. 2009, 10: 59-10.1186\/1465-9921-10-59. doi:10.1186\/1465-9921-10-59","journal-title":"Respir Res"},{"key":"496_CR4","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1185\/03007995.2011.583230","volume":"27","author":"K Fitch","year":"2011","unstructured":"Fitch K, Iwasaki K, Pyenson B, Plauschinat C, Zhang J: Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis. Curr Med Res Opin. 2011, 27: 1425-1429. 10.1185\/03007995.2011.583230.","journal-title":"Curr Med Res Opin"},{"key":"496_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2165\/00002512-200623050-00005","volume":"23","author":"RA Incalzi","year":"2006","unstructured":"Incalzi RA, Corsonello A, Pedone C, Masotti G, Bellia V, Grassi V, Rengo F: From Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines to current clinical practice: an overview of the pharmacological therapy of stable chronic obstructive pulmonary disorder. Drugs Aging. 2006, 23: 411-420. 10.2165\/00002512-200623050-00005.","journal-title":"Drugs Aging"},{"key":"496_CR6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1183\/09031936.01.00213701","volume":"18","author":"N Roche","year":"2001","unstructured":"Roche N, Lepage T, Bourcereau J, Terrioux P: Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease. Eur Respir J. 2001, 18: 903-908. 10.1183\/09031936.01.00213701.","journal-title":"Eur Respir J"},{"key":"496_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1378\/chest.06-2846","volume":"132","author":"MK Han","year":"2007","unstructured":"Han MK, Kim MG, Mardon R, Renner P, Sullivan S, Diette GB, Martinez FJ: Spirometry utilization for COPD: how do we measure up?. Chest. 2007, 132: 403-409. 10.1378\/chest.06-2846.","journal-title":"Chest"},{"key":"496_CR8","volume-title":"Int J Circumpolar Health","author":"S Olsen","year":"2013","unstructured":"Olsen S, Jarb\u00f8l DE, Kofoed M, Abildskov K, Pedersen ML: Prevalence and management of patients using medication targeting obstructive lung disease: a cross-sectional study in primary healthcare in Greenland. Int J Circumpolar Health. 2013, 72: doi:10.3402\/ijch.v72i0.20108"},{"key":"496_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3109\/15412550903341455","volume":"6","author":"PC Chavez","year":"2009","unstructured":"Chavez PC, Shokar NK: Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic. COPD. 2009, 6: 446-451. 10.3109\/15412550903341455.","journal-title":"COPD"},{"key":"496_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.rmed.2009.10.023","volume":"104","author":"M Arne","year":"2010","unstructured":"Arne M, Lisspers K, St\u00e4llberg B, Boman G, Hedenstr\u00f6m H, Janson C, Emtner M: How often is diagnosis of COPD confirmed with spirometry?. Respir Med. 2010, 104: 550-556. 10.1016\/j.rmed.2009.10.023.","journal-title":"Respir Med"},{"key":"496_CR11","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/j.rmed.2012.09.012","volume":"106","author":"MM Koefoed","year":"2012","unstructured":"Koefoed MM, de Pont Christensen R, S\u00f8ndergaard J, Jarb\u00f8l DE: Lack of spirometry use in Danish patients initiating medication targeting obstructive lung disease. Respir Med. 2012, 106: 1743-1748. 10.1016\/j.rmed.2012.09.012.","journal-title":"Respir Med"},{"key":"496_CR12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2340\/1650197719702239298","volume":"2","author":"G Borg","year":"1970","unstructured":"Borg G: Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med. 1970, 2: 92-98.","journal-title":"Scand J Rehabil Med"},{"key":"496_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1477-7525-1-13","volume":"1","author":"T Van der Molen","year":"2003","unstructured":"Van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF: Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003, 1: 13-10.1186\/1477-7525-1-13.","journal-title":"Health Qual Life Outcomes"},{"key":"496_CR14","volume-title":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease","author":"GOLD","year":"2006","unstructured":"GOLD: Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2006, http:\/\/www.goldcopd.org\/Guidelines\/guidelines-global-strategy-for-diagnosis-management-2006.html . (Accessed April 2014)"},{"key":"496_CR15","volume-title":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease","author":"GOLD","year":"2010","unstructured":"GOLD: Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2010, http:\/\/www.goldcopd.org\/Guidelines\/guideline-2010-gold-report.html . (Accessed April 2014)"},{"key":"496_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0140-6736(03)12459-2","volume":"361","author":"P Calverley","year":"2003","unstructured":"Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C: TRial of Inhaled STeroids ANd long-acting beta2 agonists study group: Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2003, 361: 449-456. 10.1016\/S0140-6736(03)12459-2.","journal-title":"Lancet"},{"key":"496_CR17","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1164\/rccm.2112055","volume":"166","author":"DA Mahler","year":"2002","unstructured":"Mahler DA, Wire P, Horstman D, Chang C-N, Yates J, Fischer T, Shah T: Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002, 166: 1084-1091. 10.1164\/rccm.2112055.","journal-title":"Am J Respir Crit Care Med"},{"key":"496_CR18","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1378\/chest.124.3.834","volume":"124","author":"NA Hanania","year":"2003","unstructured":"Hanania NA, Darken P, Horstman D, Reisner C, Lee B, Davis S, Shah T: The efficacy and safety of fluticasone propionate (250 microg)\/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD. Chest. 2003, 124: 834-843. 10.1378\/chest.124.3.834.","journal-title":"Chest"},{"key":"496_CR19","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1378\/chest.11-0831","volume":"141","author":"AS Gershon","year":"2012","unstructured":"Gershon AS, Victor JC, Guan J, Aaron SD, To T: Pulmonary function testing in the diagnosis of asthma: a population study. Chest. 2012, 141: 1190-1196. 10.1378\/chest.11-0831.","journal-title":"Chest"},{"key":"496_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3132\/pcrj.2008.00047","volume":"18","author":"J Buffels","year":"2009","unstructured":"Buffels J, Degryse J, Liistro G: Diagnostic certainty, co-morbidity and medication in a primary care population with presumed airway obstruction: the DIDASCO2 study. Prim Care Respir J. 2009, 18: 34-40. 10.3132\/pcrj.2008.00047.","journal-title":"Prim Care Respir J"},{"issue":"5 Suppl 2","key":"496_CR21","doi-asserted-by":"publisher","first-page":"398S","DOI":"10.1378\/chest.117.5_suppl_2.398S","volume":"117","author":"R Rodriguez-Roisin","year":"2000","unstructured":"Rodriguez-Roisin R: Toward a consensus definition for COPD exacerbations. Chest. 2000, 117 (5 Suppl 2): 398S-401S.","journal-title":"Chest"},{"key":"496_CR22","doi-asserted-by":"publisher","first-page":"46s","DOI":"10.1183\/09031936.03.00078002","volume":"41","author":"S Burge","year":"2003","unstructured":"Burge S, Wedzicha JA: COPD exacerbations: definitions and classifications. Eur Respir J Suppl. 2003, 41: 46s-53s.","journal-title":"Eur Respir J Suppl"},{"key":"496_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.rmed.2003.09.001","volume":"98","author":"R Pauwels","year":"2004","unstructured":"Pauwels R, Calverley P, Buist AS, Rennard S, Fukuchi Y, Stahl E, L\u00f6fdahl CG: COPD exacerbations: the importance of a standard definition. Respir Med. 2004, 98: 99-107. 10.1016\/j.rmed.2003.09.001.","journal-title":"Respir Med"},{"issue":"5 Pt 1","key":"496_CR24","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","volume":"157","author":"TA Seemungal","year":"1998","unstructured":"Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA: Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998, 157 (5 Pt 1): 1418-1422.","journal-title":"Am J Respir Crit Care Med"},{"key":"496_CR25","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1164\/rccm.200708-1290OC","volume":"177","author":"L Langsetmo","year":"2008","unstructured":"Langsetmo L, Platt RW, Ernst P, Bourbeau J: Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med. 2008, 177: 396-401. 10.1164\/rccm.200708-1290OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"496_CR26","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1136\/bmj.320.7245.1297","volume":"320","author":"PS Burge","year":"2000","unstructured":"Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK: Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ. 2000, 320: 1297-1303. 10.1136\/bmj.320.7245.1297.","journal-title":"BMJ"},{"key":"496_CR27","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.rmed.2012.03.008","volume":"106","author":"A Corrado","year":"2012","unstructured":"Corrado A, Rossi A: How far is real life from COPD therapy guidelines? An Italian observational study. Respir Med. 2012, 106: 989-997. 10.1016\/j.rmed.2012.03.008.","journal-title":"Respir Med"},{"key":"496_CR28","volume-title":"[Physicians: Estimations on January 1, 2008. Statistical Series, No. 127, October 2008] in French","author":"DREES (French Ministry of Health Directorate for Research, Evaluation and Statistics)","year":"2013","unstructured":"DREES (French Ministry of Health Directorate for Research, Evaluation and Statistics): [Physicians: Estimations on January 1, 2008. Statistical Series, No. 127, October 2008] in French. 2013, http:\/\/www.drees.sante.gouv.fr\/IMG\/pdf\/seriestat127.pdf . (Accessed September 2013)"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2466-14-56.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2466-14-56\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2466-14-56","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2466-14-56.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:13:44Z","timestamp":1689102824000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/1471-2466-14-56"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["496"],"URL":"https:\/\/doi.org\/10.1186\/1471-2466-14-56","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,2]]},"article-number":"56"}}